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Abstract
Background: Lung cancer is the leading cause of death in Taiwan for years. Besides the currently used chemotherapy,
herbal medicine may play a role in the treatment of lung cancer. Hottuynia cordata THUNB (HC), one of the frequently
used herbal medicine in Taiwan, has been widely used in various diseases. Review from literatures, HC has many effects,
including anti-inﬂammatory, anti-viral, anti-bacterial, anti-SARS, and anti-tumor activities. However, there is no literatures describe its active compounds on lung cancer. This present study aims to evaluate the possible effect and action
mechanism of active compounds from HC (aristolactam BII, aristolactam AII, and noraristolodione) on lung cancer. A549
lung cancer cell line was used to evaluate the effects of HC on the cell viability and possible anti-tumor effects.
Methods: We used A549 cells in the evaluation of anticancer activity. Cell viability, cell cycle, cell apoptosis and
apoptosis related protein expression were studied.
Results: Active compounds from HC signiﬁcantly inhibited A549 cell viability and induced accumulation of cell cycle
at S or G2/M phase on A549 cells in a concentration-dependent manner, and induced A549 arrest at S or G2/M phase via
increasing p21, p27, p53 and reducing cyclin-E, -A, cyclin-dependent kinase 2 (CDK2), cdc-2 (CDK1) protein expression.
Additionally, HC induced A549 cell late apoptosis by up-regulating caspase-3, -8, Bax and decreasing Bcl-2 protein
expression.
Conclusions: The anti-tumor effects of aristolactam BII, aristolactam AII, and noraristolodione on human lung carcinoma A549 cells were via cell cycle arrest and apoptosis.
Keywords: Hottuynia cordata THUNB, Anti-lung cancer, Aristolactam BII, Aristolactam AII, Noraristolodione, Cell cycle
arrest, Apoptosis

1. Introduction

L

ung cancer is the leading cause of cancer
death in Taiwan and other countries for years
[1]. In many countries in Europe and America,
lung cancer is also cancer with the highest mortality rate [2]. How to prevent and effectively treat
lung cancer to reduce its incidence and mortality
is an important issue.

In addition to current chemotherapy, the use of
Chinese herbal medicine may have a reference
value for lung cancer [3]. Houttuynia cordata THUNB
(Saururaceae; in abbreviation HC) is a very
commonly used herbal medicine in Taiwan. The
crude water layer of HC has anti-inﬂammatory activity [4,5]. It has anti-inﬂammatory activity against
nitric oxide (NO) and tumor necrosis factor-alpha
(TNF-a) in the RAW264.7 cell line [3]. HC injection
can inhibit carrageenan-induced pleurisy in rats
and xylene-induced ear edema in mice [5]. The
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polyphenols in HC have antioxidant effects. For
example, ﬂavonoids can decompose the free radicals generated by oxidative stress in patients with
diabetes [4-6]. Water extract of HC protects against
bleomycin-induced pulmonary ﬁbrosis [7]. HC can
reduce viral plaque formation and reduce viral RNA
synthesis, increase viral apoptosis [8]; it can also
reduce the replication of herpes virus (HSV-2) achieve anti-viral infection activity [9]. Hot water extract
of HC can effectively inhibit the growth of human
leukemia cells [10].
Water layer extract of HC can stimulate the proliferation of mouse spleen lymphocytes by
increasing the secretion of IL-2 and IL-10 of visceral
lymphocytes, and at the same time increase the
CD4þ and CD8þ T cells of the immune system; in
terms of anti-virus, it shows inhibitory effects on
SARS-CoV 3C-like protease (3CLpro) and RNAdependent RNA polymerase (RdRp) [11]. Six active
alkaloids derived from the methanol extraction of
HC are aristolactam BII, piperolactam A, aristolactam AII, norcepharadione B, cepharadione B, and
splendidine, which can effectively inhibit the
growth of ﬁve human cancer cell lines. Non-small
cell lung cancer (A549), ovarian cancer (SK-OV-3),
melanoma (SK-MEL-2), central nervous system
cancer cells (XF-498) and colon cancer (HCT-15) are
included [12,13]. However, there are no reposts
regarding the action mechanisms of these active
alkaloids on human lung cancer.
This study evaluated the possible effect and action
mechanism of active alkaloids from HC on lung
cancer. We used the A549 lung cancer cell line to
evaluate HC's effects on cell viability and possible
anti-tumor effects.

2. Materials and Methods
2.1. Active alkaloids from HC
Five active alkaloids derived from the methanol
extraction of Houttuynia cordata (HC), aristolactam
BII, aristolactam AII, piperolactam A, norcepharadione B, and noraristolodione were prepared and
identiﬁed by Prof. Wu TS's lab.
2.2. Chemicals and reagents
RPMI cell culture medium, FBS (fetal bovine
serum), P/S (penicillin-streptomycin), and trypan
blue were purchased from Gibco BRL USA. DMSO
(dimethyl sulfoxide), PI (propidium iodide), RNase
A (ribonuclease A), BSA (bovine serum albumin),
APS (ammonium persulfate), MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide),
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Cellytic ™ M cell lysis reagent, Triton X-100 were
from Sigma-Aldrich Chemical company, USA.
TEMED
(NeNeN0 -N0 -Tetramethylenediamine),
Tween-20 (polyoxyethylenesorbitan monolaurate),
trypran-EDTA, 40% acrylamide/BIS- ACRYLAMIDE (29:1 Ratio), 10X SDS (sodium dodecylsulfate)
buffer,
Tris
(tris(hydroxymethy)aminomethane), 10X SDS-PAGE running buffer
(TG-SDS buffer) were from Amersco company,
USA. Apoptosis detection kit (PI/Annexin V-FITC)
was from Becton Dickinson, USA. Western lightning
chemiluminescene reagent plus (ECL) kit was from
NEN Life Science, USA. Anti-cyclin A (ab7956), anticyclin E (ab7959), anti-CDk1/Cdc2 (ab6537), antiCdk2 (ab7954), Anti-p27K1P1 (ab47590), Anti-p21
(ab47452), goat anti-mouse IgG (HRP) horseradish
peroxide conjugated antibody were from Abcam
company. b-Actin (C4): sc-477778, caspase-3 (H277): sc-7418, caspase-8 p20 (H-134):sc-7890, were
from Santa Cruz biotechnology.
2.3. Cell culture
Human lung cancer A549 cells were from BCRC
(the Bioresource Collection and Research Center) in
Hsinchu, Taiwan. A549 cells were maintained in
RPMI-1640 medium containing 100 ml/L FBS and
100,000 U/L penicillin/100 mg/L streptomycin.
2.4. Cell viability
A549 cells were plated onto 96-well plates and
incubated with different concentrations (12,5 mg/ml,
25 mg/ml, 50 mg/ml) of ﬁve alkaloids from HC
(including aristolactam BII, aristolactam AII, piperolactam A, norcepharadione B, and noraristolodione) for 24 hr. MTT was added to each well
and incubated for another 1 h at 37 C. Dissolved the
blue formazan product in 200 ml DMSO for 15 min,
and then the plates were read using a spectrophotometric plate reader (Bio-Rad, Japan) at O.D.
570nm.
2.5. Cell cycle distribution and apoptosis
determination
A549 cells were plated onto 12-well plates and
incubated with different concentrations (12,5 mg/ml,
25 mg/ml, 50 mg/ml) of 3 alkaloids from HC
(including aristolactam BII, aristolactam AII, and
noraristolodione) for 24 hr. Fixed cells in 75%
ethanol at 4  C for overnight and resuspended in 1X
PBS containing PI (40 mg/ml), RNase (0.1 mg/ml)
and Triton X-100 (0.1%) for 30 min. Cell cycle distribution and apoptosis determination were
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analyzed by ﬂow cytometry (FACS Calibur, Becton
Dickinson, USA) as previously described [13].
2.6. Western blotting
A549 cells were plated onto 10-cm plates and
treated with various concentrations (12,5 mg/ml, 25
mg/ml, 50 mg/ml) of aristolactam BII, aristolactam
AII, and noraristolodione for 24 hr. Total cell lysates
were prepared as previously described [13]. Applied
forty mg of total protein to SDS-PAGE and transferred onto a PVDF (polyvinylidene ﬂuoride)
membrane. Then, incubated the blots with the
appropriate dilution of speciﬁc monoclonal antibodies for cyclin E, cyclin A, CDK2, cdc 2, p21, p27,
p53, caspase 3, caspase 8, Bax and Bcl-2. Using
enhanced chemiluminescence kits (ECL kit) to
detect protein expressions [13].
2.7. Statistical analysis
The experiments were performed at least in triplicate and all data were expressed as the mean ±
standard error. Student's t-test and one-way
ANOVA followed by Dunnett's test were used for
single variable comparison and multiple variable
comparisons, respectively. Signiﬁcance was considered when P < 0.05.

3. Results
3.1. Effects of alkaloids from HC on the viability of
A549 cells
Various doses (12.5 mg/ml, 25 mg/ml, 50 mg/ml) of
active compounds (aristolactam BII, aristolactam
AII, piperolactam A, norcepharadione B, and noraristolodione) from HC treated with A549 cells for
24 h, and the cell viability was detected by MTT
tests. These compounds showed a dose-dependent
inhibition on the cell viability of human lung cancer
A549 cells, *P < 0.05, **P < 0.01, and ***P < 0.001 (as
shown in Fig. 1).

Fig. 1. Effects of active compounds (aristolactam BII, aristolactam AII,
piperolactam A, norcepharadione B, and noraristolodione) on cell viability
of human lung cancer A549 cells. Various concentrations (12.5 mg/ml, 25
mg/ml, 50 mg/ml) of these active compounds treated with A549 cells for 24
h. Detected the cell viability by MTT tests. Results were represented as
vertical bars and mean ± S.E. *P < 0.05, **P < 0.01, ***P < 0.001 was
considered statistically signiﬁcant compared to the control group.

3.3. Effect of alkaloids from HC on the cell cyclerelated and apoptosis-related proteins of A549 cells
Alkaloids (aristolactam BII, aristolactam AII, and
noraritoldione) from HC decreased the cyclin A,
cyclin E, CDK 2, and Cdc2 (CDK1) proteins related
to the S phase and G2/M phase of the cell cycle in a
dose-dependent manner (*P < 0.05, **P < 0.01, and
***P < 0.001, as shown in Figs. 5e7). Alkaloids from
HC
concentration-dependent
increased
the

3.2. Effects of alkaloids from HC on the cell cycle of
A549 cells
The DNA content of the cell cycle is highest in the
G1 phase, followed by the S phase, and the G2/M
phase is the least. Compared to the control group,
the alkaloids aristolactam BII and aristolactam AII
produced the S phase and G2/M phase accumulation (*P < 0.05, **P < 0.01, and ***P < 0.001, as
shown in Fig. 2 and Fig. 3), and noraristolodione
only caused accumulation in the S phase (**P < 0.01,
as shown in Fig. 4)

Fig. 2. Effects of different concentrations (12.5 mg/ml, 25 mg/ml, and
50 mg/ml) of aristolactam BII on A549 cell cycle distribution. Aristolactam BII treatment for 24 h altered A549 cell-cycle distribution and
arrested at S/G2/M phase. Results were represented as vertical bars and
mean ± S.E. *P < 0.05, **P < 0.01, ***P < 0.001 was considered
statistically signiﬁcant compared to the control group.

Fig. 3. Effects of different concentrations (12.5 mg/ml, 25 mg/ml, and 50
mg/ml) of aristolactam AII on A549 cell cycle distribution. Aristolactam
AII treatment for 24 h altered A549 cell-cycle distribution and arrested
at S/G2/M phase. Results were represented as vertical bars and mean ±
S.E. *P < 0.05, **P < 0.01, ***P < 0.001 was considered statistically
signiﬁcant compared to the control group.

apoptosis-related protein p21, p27, P53, caspase 3
and caspase 8, and Bax. However, the survival
protein Bcl-2 was reduced (*P < 0.05, **P < 0.01, and
***P < 0.001, as shown in Figs. 5e7).

4. Discussion
According to previous reports, Houttuynia cordata
(HC) does affect some human cancer cell lines, such
as non-small cell lung cancer (A549 cells), ovarian
cancer (SK-OV-3 cells), and melanoma (SK-MEL-2
cells) [12,13]. HC has anti-growth effects on central
nervous system cancer cells (XF-498 cells) and colon
cancer (HCT-15 cells) [12]. HC has anti-lung cancer

Fig. 4. Effects of different concentrations (12.5 mg/ml, 25 mg/ml, and 50
mg/ml) of noraristolodione on A549 cell cycle distribution. Noraristolodione treatment for 24 h altered A549 cell-cycle distribution and
arrested at S/G2/M phase. Results were represented as vertical bars and
mean ± S.E. *P < 0.05, **P < 0.01, ***P < 0.001 was considered
statistically signiﬁcant compared to the control group.
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activity by interfering cell cycle; it modulates G0/G1
arrest and stimulates the Fas/CD95 protein level
[13]. Thus, leads to caspase-8 and caspase-3 activation and resulting in the induction of apoptosis in
human lung cancer A549 cells [13]. At present,
chemotherapy and radiotherapy are mostly used for
the treatment of lung cancer in clinical practice
[14,15], all of which have side effects. In order to
provide a reference for the clinical application of
HC, the anti-cancer mechanism of active compounds from HC is studied.
Previous results show HC extract modulates G0/
G1 arrest and Fas/CD95-mediated death receptor
apoptotic cell death in human lung cancer A549 cells
[13]. The mechanism of HC extract on A549 cells is
reducing the expression of cyclin D1, cyclin E, cyclin
A, and CDK4/CDK6 and CDK2 proteins in the cell
cycle, and increasing the expression of p27KIP1
Arrest A549 cells in the G1/S phase, and activate the
external pathways of caspase 3 and caspase 8 to
promote cell apoptosis [13].
There were about 44 compounds isolated from the
whole plant of HC [16]. Based on the toxic effect of
the crude extracts on A549 cells, it may be derived
from the alkaloids contained in HC. After testing
ﬁve kinds of alkaloids from HC revealed that three
of them have a signiﬁcant inhibitory effect on A549
cells. Treated A549 cells with different concentrations of these alkaloids revealed a decrease of the
survival rate (as shown in Fig. 1). These three alkaloids, aristolactam BII, aristolactam AII and noraristolodione, were used to explore their effects on
A549 cells. Under the treatment of aristolactam BII
and aristolactam AII, A549 cells were found to
accumulate in S phase or G2/M phase, that is, cell
cycle growth stopped in S phase or G2/M (as shown
in Figs. 2 and 3). Under the treatment of noraristolodione, the cell cycle of A549 cells was arrested
in S phase (as shown in Fig. 4), and treated these
alkaloids at 50 mg/ml will promote A549 cell
apoptosis.
The protein expression level results revealed that
aristolactam BII and aristolactam AII dose-dependently decreased the cyclin E, cyclin A, CDK 2, and
Cdc 2 proteins in the S phase or G2/M phase.
However, aristolactam BII and aristolactam AII
dose-dependently increased the p21, p27, and p53 of
the cell cycle protein, and the apoptosis-related
proteins caspase 3, caspase 8, Bax. Aristolactam BII
and aristolactam AII dose-dependently decreased
Bcl-2 expression level, as shown in Figs. 5 and 6. As
to noraristolodione, it dose-dependently inhibited
cyclin E, cyclin A, CDK 2, and dose-dependently
decreased the p21, p27, p53 of the cell cycle protein.
It dose-dependently increased caspase 3, caspase 8,
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Fig. 5. Various concentrations (12.5 mg/ml, 25 mg/ml, and 50 mg/ml) of aristolactam BII treated A549 cells for 24 h suppressed CDKs, cyclins, Bcl-2
protein expression and up-regulation of apoptotic protein (caspase 3, caspase 8, p21, p27, p53, and Bax) expression (A). Protein/b actin level (%)
presented in (B). The experiments were done in triplicate with similar results and used the blot of b actin as a loading control. *P < 0.05, **P < 0.01,
***P < 0.001 was considered statistically signiﬁcant compared to the control group.

Fig. 6. Various concentrations (12.5 mg/ml, 25 mg/ml, and 50 mg/ml) of aristolactam AII treated A549 cells for 24 h suppressed CDKs, cyclins, Bcl-2
protein expression and up-regulation of apoptotic protein (caspase 3, caspase 8, p21, p27, p53, and Bax) expression (A). Protein/b actin level (%)
presented in (B). The experiments were done in triplicate with similar results and used the blot of b actin as a loading control. *P < 0.05, **P < 0.01,
***P < 0.001 was considered statistically signiﬁcant compared to the control group.

Y.-F. CHEN ET AL
ANTI-LUNG CANCER ACTIVITY OF HOTTUYNIA CORDATA THUNB

45
ORIGINAL ARTICLE

BioMedicine
2021;11(2):40e46

Fig. 7. Various concentrations (12.5 mg/ml, 25 mg/ml, and 50 mg/ml) of noraristolodione treated A549 cells for 24 h suppressed CDKs, cyclins, Bcl-2
protein expression and up-regulation of apoptotic protein (caspase 3, caspase 8, p21, p27, p53, and Bax) expression (A). Protein/b actin level (%)
presented in (B). The experiments were done in triplicate with similar results and used the blot of b actin as a loading control. *P < 0.05, **P < 0.01,
***P < 0.001 was considered statistically signiﬁcant compared to the control group.

Bax protein level and dose-dependently decreased
Bcl-2 expression (as shown in Fig. 7). p53 is a transcription factor that is responsible for regulating the
balance between normal cell growth and apoptosis.
There are a large number of variability p53 in cancer
cells [17,18]. According to the experimental results,

the alkaloids in HC can inhibit the activity of A549
cells by inﬂuencing cell cycle-related proteins and
apoptosis-related proteins. It may be that p21/p27
increase by activating p53 on the one hand, allowing
A549 cell cycle arrest; on the other hand, by
increasing the expression of Bax, caspase 8, and
caspase 3 and reducing Bcl-2 activity [19].

5. Conclusions
From the above results, alkaloids from HC
reduced cyclin E, cyclin A, CDK2, and Cdc2 (CDK1)
of the cell cycle of A549 cells, and increased the
expression of p21cip, p27KIP1, and p53 proteins, so
that A549 cells were stagnant. In the S or G2/M
phase, while increasing caspase 3, caspase 8, Bax
and reducing the protein expression of Bcl-2. A549
cells underwent apoptosis through internal and
external pathways. The anti-tumor effects of aristolactam BII, aristolactam AII, and noraristolodione on
human lung cancer A549 cells were via cell cycle
arrest and apoptosis (as shown in Fig. 8).
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